°®Àê¯gÔ¸sªx«ü¥þ¨¬Y¨t²Î©Î¾¹©xµo¥Í°®Àꪺ²{¶H¡AÁ{§É¯gª¬¥]¬A¥Ö½§°®Àê¡B¤f°®¡B²´°®¡B°®Àê©Êµ²½¤ª¢¡B¨¤½¤ª¢¡B¨¤½¤¼ìºÅ¡B»óÂH½¤°®Àê¡B»ó¥X¦å¡B©I§l¹D°®Àê¡B°®«y¡B¦Õ»ï¡BÀY©ü¡B¨Å餣¥¿Å·P¡B³±¹D°®Àêµ¥¡C°®Àê¯g¦nµo¥Í©ó¦Ñ¦~¤H¡B°±¸g«áªº°ü¤k©M¨ã¦³¹L±ÓÅé½è©ÎµJ¼{¯gªº¯f¤H¨¤W¡C¤Þ°_°®Àê¯gªºì¦]«Ü¦h¡A³Ì±`¨£ªº¬O¨Åé¦Ñ¤Æ²{¶H©ÎÃĪ«ªº°Æ§@¥Î¡F¨ä¥Lì¦]ÁÙ¥]¬A¯f¬r·P¬V¡B¥NÁ©ʯe¯f¡B¸~½F©M¦ÛÅé§K¬Ì¯e¯fµ¥¡C
×®æÄõ¤ó¯gÔ¸s ( Sj?gren¡¦s syndrome)¬O¤@ºØ¦ÛÅé§K¬Ì¯e¯f¡A¥¦¥i¥H³æ¿Wµo¥Í©Î¦ñÀH¨ä¥L¦ÛÅé§K¬Ì¯e¯f¡A¨Ò¦p¡GÃþ·Àã©ÊÃö¸`ª¢¡B¬õ´³©Ê¯T½H©ÎºC©Ê¥Òª¬¸¢ª¢µ¥¡C¥Î¨Ó¶EÂ_ìµo©Ê×®æÄõ¤ó¯gÔ¸sªº¤ÀÃþ¼Ð·Ç¥H2002¦~¼Ú¬ü±M®aªº¦@ÃѬ°¥D¡F¬Û¸û©ó¥H«eªº¶EÂ_¼Ð·Ç¡A³è²G¸¢¤Á¤ùªº²Õ´ÅܤÆ(lymphocyte aggregation score ¡Ù1)»P¦å²Manti-SSA©Îanti-SSB§ÜÅé§e¶§©Ê¤ÏÀ³¡A¨ä¤¤¤@¶µ³Q¦C¬°¥²³Æ±ø¥ó¤§¤@¡C×¥¿«áªºcriteria´£¤É¤F¶EÂ_ªºspecificity¡C¹ï©óanti-SSA§ÜÅé³±©Ê¡Aanti-SSB§ÜÅé³±©Ê¡ALip biopsy¶§©Ê¤§¯f¨Òn«D±`¤p¤ß¡A¥¦¥i¯à¤£¬O×®æÄõ¤ó¯gÔ¸s¡A¦¹®É²O¤ÚÀù¡BºC©ÊHBV/HCV·P¬V¡BSaroidosis¬Ò¥²¶·¦C¤JŲ§O¶EÂ_¡C
×®æÄõ¤ó¯gÔ¸s°£¤F¤Þ°_¥~¤Àªc¸¢ªº¥\¯à»Ùê¥~¡AÄY«ªÌÁÙ·|«I¥Ç¤ºÅ¦¾¹©x¤Þ°_¶¡½è©ÊªÍª¢¡BºC©Ê¬¡°Ê©ÊªÍª¢¡B¶¡½è©ÊµÇª¢©Î¦åºÞª¢µ¥¡C¶¡½è©ÊªÍª¢¥HNon-specific interstitial pneumonitis (NSIP)»Plymphocytic interstitial pneumonitis (LIP)¬°¥D¡A¨ä¥L¤Ö¨£¤§ªÍ³¡«I¥Ç¦³middle lobe syndrome, bronchiolitis obliteransµ¥
ªvÀøìµo©Ê×®æÄõ¤ó¯gÔ¸sªº¥DnÃĪ«¦³¡Gƒñ«P¶i³è²G¤Àªc¤§ÃĪ«¡A¨Ò¦p¡Gpilocarpin (SalagenR)»Pcimevuline (Evoxac)¡Fƒò§K¬Ì½Õ¸`¾¯¡A¨Ò¦p¡Ghydroxychloroquine©Îprednisoloneµ¥¡C·U¦±µ¨ü¾A·íªvÀø¡A²´°®/¤f°®§ï¶iªº¾÷²v»Pµ{«×¬Ò·|¤j¤j´£¤É¡F¤@¦ý¦³¤ºÅ¦¾¹©x«I¥Ç¡A¥²¶·¤Î®É±µ¨ü§K¬Ì½Õ¸`§í¨î¾¯ªºªvÀø¡C
|